In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach
Journal of Biomolecular Structure and Dynamics · 2024-01-22 · 42 (2) · 1072-1078
DOI: 10.1080/07391102.2023.2201848 ↗At a glance
Journal article in Journal of Biomolecular Structure and Dynamics, published online on 2023-05-03. Written by Madeswaran Arumugam and 3 co-authors. Institution: Department of Pharmacology, Karpagam College of Pharmacy, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Coimbatore, Tamil Nadu, India. Major MEDLINE topics: COVID-19, Triterpenes, Lupanes. Cited 7 times so far (Crossref); 27 references.
Abstract (original language)
Coronavirus, an extremely contagious infections disease had a harmful effect on the world's population. It is a family of enveloped, single-stranded, positive-strand RNA viruses of Nidovirales order belongs to coroviridae family. At present, worldwide several lakhs of deaths and several billions of infections have been reported. Hence, the focus of the present study was to assess the SARS-CoV-2 enzyme inhibitory potential of certain commercially available terpenoids using Lamarckian genetic algorithm as a working principle and molecular dynamic studies was also performed. AutoDock 4.2 software was used to perform the computational docking calculations of terpenoids against SARS-CoV-2 enzyme. The terpenoids such as, Andrographolide, Betulonic acid, Erythrodiol, Friedelin, Mimuscopic acid, Moronic acid, and Retinol were selected based on the drug likeness properties. Remdesivir a well-known anti-viral drug was selected as the standard drug. Molecular dynamic simulation studies were carried using Desmond module of Schrodinger Suite. In the current study we observed that, Friedelin was exhibited excellent SARS-CoV-2 enzyme inhibitory potential than the standard drug and other selected terpenoids. Friedelin and the standard Remdesivir was undergone the molecular dynamic studies and Friedelin showed a good number of hydrogen bonds over the simulation time of 100 ns. Based on the in silico computational evaluation, it can be concluded that Friedelin could be worthwhile terpenoid against SARS-CoV-2 spike protein. A further study on Friedelin is required to develop a potential chemical entity against the management of COVID disease.Communicated by Ramaswamy H. Sarma.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology, Karpagam College of Pharmacy, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Coimbatore, Tamil Nadu, India.
- Department of Pharmacology, Sri Ramakrishna Institute of Paramedical Sciences, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Coimbatore, Tamil Nadu, India.
- Karpagam College of Pharmacy, Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Coimbatore, Tamil Nadu, India.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India.
ORCID profiles: Madeswaran Arumugam
Cite
APA
Arumugam, M., Shanmugavel, B., Sellppan, M., & Pavadai, P. (2024). In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach. Journal of Biomolecular Structure and Dynamics, 42(2), 1072-1078. https://doi.org/10.1080/07391102.2023.2201848
Vancouver
Arumugam M, Shanmugavel B, Sellppan M, Pavadai P. In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach. Journal of Biomolecular Structure and Dynamics. 2024;42(2):1072-1078. doi:10.1080/07391102.2023.2201848
BibTeX
@article{Arumugam2024,
author = {Arumugam, Madeswaran and Shanmugavel, Brahmasundari and Sellppan, Mohan and Pavadai, Parasuraman},
title = {In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach},
journal = {Journal of Biomolecular Structure and Dynamics},
year = {2024},
volume = {42},
number = {2},
pages = {1072--1078},
doi = {10.1080/07391102.2023.2201848}
}
EUVIMED